Supurva Expects Major Breakout Year in 2015; Upwards of $2 Million in Revenues Expected Over The Next Twelve Months

COVINGTON, LA / ACCESSWIRE / July 16, 2015 / Supurva Healthcare Group, Inc. (Formerly known as Lighthouse Petroleum, Inc.) (Supurva or the Company) (OTC Markets: SPRV), is pleased to announce today that the Company has upgraded the letter of intent (LOI) to acquire Telemend Medical (Telemend) announced on July 8, 2015 to now include existing clinical engineering contracts with various government entities nationwide. Under these additional contracts, the Company will be initiating a hybrid of clinical engineering and IT services alongside the Companys mobile healthcare services providing for a best-in-class telemedicine delivery system. These contracts are expected to add in excess of $400,000 in revenues over the next twelve months to the total acquisition package. This is in addition to the other contracts under the LOI to provide services to 35 dental facilities in the Greater Houston area that are expected to generate more than $1.6 million in revenues for the Company over the next twelve months.

Current CEO of Telemend, Sheneka Rains, has agreed to remain as CEO of Telemend after its acquisition and will also serve as COO of Supurva. After completion of the transaction, she will be well positioned for further expansion of the Company, bringing with her many years of experience managing clinical engineering contracts and having established operational excellence amongst a variety of healthcare business models. In her tenure as CEO of Telemend, Ms. Rains has doubled total customer accounts and tripled revenue.

Gerard Danos, CEO of Supurva stated, Clinical engineering will provide a steady revenue stream that will allow us to far exceed our projected targets for 2015. This level of revenues will enable the Company to quickly reach its goal to achieve fully reporting status as soon as possible. I am also thrilled that Ms. Rains will join our organization to ensure a smooth transition of existing customers as well as establish operational systems that will facilitate additional future acquisitions.

About Supurva Healthcare Group, Inc.

Supurva Healthcare Group, Inc., a Delaware Corporation, is a healthcare holdings company based in Covington, LA. Supurva, through its wholly own subsidiary On Site Solutions, LLC, provides on-site healthcare for acute, subacute, and nursing facility residents / patients; specializing in dentistry, podiatry, optometry, and wound care. On Site Solutions, LLC currently has arrangements with 14 long term care facilities in Texas in its growing portfolio totaling roughly 1200 beds.

Forward Looking Statement

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe future expectations, plans, results, or strategies and are generally preceded by words such as may, future, plan or planned, will or should, expected, anticipates, draft, eventually or projected. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks. Supurva Healthcare Group, Inc. is a healthcare holdings company. At the time of this release Supurva Healthcare Group, Inc. lacks the financial capabilities to meet its financial obligations and its management expects to dilute the companys shares to raise the necessary operating capital. Based upon industry standards Supurva would be considered highly speculative and lacks any competitive advantage over its competition. Additional risks you should consider are that this list is limited and additional risk not mentioned may apply: failure to meet Supurvas financial and contractual obligations, Supurvas managerial errors made based upon the Companys limited experience and knowledge of the industry, acts of God and regulatory risk. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.

Contact

Gerard Danos, Chairman
Supurva Healthcare Group, Inc.
info@supurvahealthcare.com
1-985-237-3701

SOURCE: Supurva Healthcare Group, Inc.

ReleaseID: 430636

Lupo to Take Over Weeddepot.Com and Related Sites

SCOTTSDALE, AZ /ACCESSWIRE / July 16, 2015 / Northsight Capital, Inc. (PINKSHEETS: NCAP), announced that Bill Lupo, one of the most seasoned executives in the cannabis space has accepted the position of CEO and will take over company operations immediately. Lupo will also go on the Board of Directors. Lupo was previously the COO of Weedmaps.com, the leading company in the Cannabis space, and COO of Ghost Group, a venture firm concentrating on the marijuana business.

Lupo, an is accomplished Digital and Media veteran with a 15-year track record of leadership, management, growth experience in Fortune 100 and early stage companies, across Adtech, Search, E-Commerce, Content, Saas, and Mobile models. His B2C and B2B background includes both work in the restructuring field, and growth companies. The former includes a senior capacity role with Deluxe Corporation’s Digital division and growth roles with VC backed companies ($1M-$100M+ by revenue in size), the majority of which having positive outcomes for investors and stakeholders.

Notable senior operating roles include contributions at Deluxe Corporation as the VP of Small Business & Digital, growing an Internet Search based product line into a $100M+ business, with over 600K+ customers. Early on Lupo was Regional Sales manager for Yodle, and AltaVista, which was acquired by Yahoo.

John Bluher, “We are absolutely thrilled to have someone with Bill’s background in the cannabis industry join the company to provide insight and leadership for the sales force and the marketing team,” said Bluher. “Bill assisted in building WeedMaps to where it is and has the knowledge and the industry experience to do the same for Weed Depot and all our marketing and advertising sites.” Bluher continued, “I came to Northsight exactly one year ago to help create the platform and to run the public company. We’ve created a state-of–art platform and are first to market with a media marketing platform for all verticals in the marijuana industry. It’s time to hand off what we built to an industry professional who can take this to the next level. I will serve as President and will focus on M&A, building the balance sheet, financial reporting, IR, and PR.”

Bill Lupo stated, “I am truly honored to be a part of the Northsight Capital family of web sites. Northsight Capital has built the first truly comprehensive digital media network in the cannabis space.” He continues by saying,”When the opportunity was presented to join the company, I immediately accepted the position. Going forward we plan on building upon our early successes by developing the premier global brand in the cannabis media space.”

About:

Northsight Capital, Inc. (NCAP) is comprised of a portfolio of online marijuana-related websites that are being developed and operated by the company. These sites will incorporate many aspects of the marijuana industry. The company intends to provide its audience with a means to stay informed on the industry’s most cutting edge marijuana-related innovations and legislation. The company’s most dynamic concept, WeedDepot.com, provides consumers with a geo-targeted map directory of medical and recreational dispensaries, head shops, doctors, attorneys and more within the marijuana industry. The Weed Depot app can be downloaded for free at the iTunes Store and Google Play. Weed Depot has an entire platform of content suited for every aspect of advertising and marketing to consumers from all businesses in the cannabis industry.

Northsight Capitals current web sites include:

www.Weeddepot.com

www.420careers.com

www.MJBizwire.com

www.MarijuanaSelfies.com (affiliate)

www.MarijuanaRecipes.com

www.RateMyStrain.com

www.WikiWeed.com

www.MarijuanaMd.com

www.MarijuanaHealthTips.com

www.MarijuanaDiscountCoupons.com (affiliate)

Forward-Looking Statements:

Various statements in this release, including those that express a belief, expectation or intention, may be considered “forward-looking statements” that involve risks and uncertainties that could cause actual results to differ materially from projected results. Accordingly, investors should not place undue reliance on forward-looking statements as a prediction of actual results. The forward-looking statements may include projections and estimates concerning the timing and success of specific projects or transactions. Forward-looking statements may also include projections and estimates concerning our future operating results and financial condition. When we use the words “will,” “believe,” “intend,” “expect,” “may,” “should,” “anticipate,” “could,” “estimate,” “plan,” “predict,” “project,” or their negatives, or other similar expressions, the statements which include those words are usually forward-looking statements. When we describe strategy that involves risks or uncertainties, we are making forward-looking statements. The forward-looking statements in this press release speak only as of the date of this press release; we disclaim any obligation to update these statements. We have based these forward-looking statements on our current expectations and assumptions about future events. While our management considers these expectations and assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory and other risks, contingencies and uncertainties, most of which are difficult to predict and many of which are beyond our control.

CONTACT:

Northsight Capital, Inc.
Info@NorthsightCapital.com
480-385-3800

SOURCE: Northsight Capital, Inc.

ReleaseID: 430634

LONDON, ENGLAND / ACCESSWIRE / July 16, 2015 / Bio-AMD, Inc. and Bio-AMD Holdings Ltd., our majority owned medical devices subsidiary (together “Bio-AMD,” “We” or the “Company”) (OTCQB: BIAD), is pleased to announce that it has recently received formal notice of a grant of a United States Patent (“Grant”) for its Low Volume Assay Apparatus used in its point of care system for the measurement of Prothrombin Time / International Normalized Ratio (“PT/INR”).

The PT/INR test is standard for patients typically on life-long oral anticoagulation therapy, enabling the regulation of therapeutic dosage to optimise their rate of blood clotting. The market for PT/INR Point of Care (“POC”) devices is estimated by BCC Research to grow to $1.1 billion globally in 2017.

The Grant, under U.S. Patent No. US 9,046,512 B2 protects twenty one claims central to the Company’s microfluidic strip and reader technology designed to test PT/INR by a POC device.

The Company’s patent protected technology requires only a very small, “finger-stick” drop of blood, with the sample’s clotting rate analysed using a disposable microfluidic strip and hand-held device. The Company believes that its patented method of PT/INR detection will enable the efficient manufacture of reliable test strips and hand held POC readers. The test is designed to match the accuracy of “Gold Standard” laboratory tests, producing automated results within minutes in the presence of the patient, at an economic cost.

Tom Barr, CEO of Bio-AMD Inc. said, “This is a major achievement for the Company. Dr Djennati and Dr Mitchell, the main inventors behind our growing patent portfolio, are to be congratulated in producing this outstanding technology and achieving the first patent grant. I expect further patent grants in other key territories related to this unique technology in due course.”

About Bio-AMD, Inc.

Bio-AMD has two majority owned UK subsidiaries: Bio-AMD Limited, a technology developer for medical diagnostic devices; and WOCU Ltd, the owner of the WOCU(R), a global currency data reference source for application in financial markets. (www.wocu.com).

To find out more about Bio-AMD (OTCQB: BIAD), visit our website at www.bioamd.com.

Forward-Looking Statements

Statements in this news release that are not statements of historical fact are forward-looking statements, which are subject to certain risks and uncertainties. Forward-looking statements can often be identified by words such as “expects,” “intends,” “plans,” “may,” “could,” “should,” “anticipates,” “likely,” “believes” and words of similar import. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Actual results may differ materially from those expressed or implied by forward-looking statements due to a variety of factors that may or may not be foreseeable or within the reasonable control of the Company. Readers are cautioned not to place undue reliance on such forward-looking statements. Additional information on risks and other factors that may affect the business and financial results of the Company can be found in filings of the Company with the U.S. Securities and Exchange Commission, including without limitation the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 filed on March 30, 2015, and in Company reports filed subsequently thereto. Except as otherwise required by law, the Company disclaims any obligations or undertaking to publicly release any updates or revisions to any forward-looking statement contained in this news release to reflect any change in the Company’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

CONTACT:

Bio-AMD, Inc.
Tom Barr, CEO
+44 (0)8445 861 910

SOURCE: Bio-AMD, Inc.

ReleaseID: 430635

A High-End Metal Vaporizer Pipe with Unparalleled Quality, Design and Function!

ANAHEIM, CA / ACCESSWIRE / July 16, 2015 / M Line Holdings, Inc. (PINKSHEETS: MLHC “M Line” or the “Company”). M Line today confirmed that it has started full production of its new Vaporizer Pipe that M Line designed in conjunction with its new customer. This new product line anticipates a run rate in additional revenues of approximately $3 million per annum. Our portable product, built of high quality metal, offers unmatched quality in design and function, with adjustable temperature control and an advanced LED display that enables customers to manage the burn. Our current design includes a mini USB recharging port.

The Vaporizing industry is a high growth sector in the tobacco industry and is a known alternative to cigarettes. The growth is in line with the shift in consumer demand away from tar laden cigarettes. Our new product strategy is to explore unconventional products that will incorporate intellectual property including patents, copyrights and trademarks as well as the development and marketing of ancillary consumer products.
 
Our products will be targeted to the high-end user market.

Bruce Barren, CEO, and Tony Anish, COO, of M Line stated: “This is the first of a series of M Line new products under consideration that we are developing with the focus of leveraging our aerospace technology in order to leap into the forefront of an exciting new industry and enhance shareholder value.”

The products and services provided by M Line’s operating subsidiaries include the following:

– M Line is a leading provider of products, assemblies and services to the precision high tech segment of both the aerospace and medical industries as well as manufacturing new products (eg. Our vaporizers) utilizing our expertise in the precision metal manufacturing arena.
– M Line sells high end pre-owned Computer Numerically Controlled (“CNC”) Machine Tool Equipment and;
– M Line now provides business financial services to other Companies needing financial support, advice and innovating thinking.

For more information on M Line, see our website at www.mlineholdings.com

Safe Harbor and Informational Statement

This press release may contain forward-looking information within the meaning of Section 21E of the Security Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statement of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company’s financing plans; (ii) trends affecting the company’s financial conditions or results of operations; (iii): the company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends.

The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend,” and similar expressions and variations thereof are intend to identify forward-looking statements. Investors are cautioned that any such forward-looking statement are not a guarantee of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the company’s statements and reports filed with the OTC Markets. The Company claims the safe harbor provided by Section 21E(c) of the Exchange Act for all forward-looking statements.

For further information contact

Tony Anish
tony@mlineholdings.com

SOURCE: M Line Holdings, Inc.

ReleaseID: 430616

PHOENIX, AZ / ACCESSWIRE / July 16, 2015 / A leader in sustainable glycol technologies, GlyEco, Inc. (“GlyEco” or the “Company”) (OTC: GLYE), announced the issuance of a letter by Interim CEO and President David Ide, to update shareholders on Company progress.

Dear Fellow Shareholders:

Since our last update to shareholders, we have a number of major milestones to report.

During our April 2015 shareholder conference call, we communicated four primary strategic objectives for the remainder of this fiscal year. I would like to take this time to update you regarding the progress made in these functional areas.

Strategic Objective #1: GlyEco will continue its dedication to quality. As we are institutionalizing our technology, our quality control and assurance program will continue to develop as the standard in the glycol industry.

Update: Our Quality Control and Assurance Program (“QC&A Program”) is the cornerstone of our Company’s recent opportunities with national brands who demand on behalf of their customers the highest quality glycol products in the market. We have institutionalized our QC&A Program throughout our footprint; our facility managing partners have created a Quality Control and Assurance Committee to support and develop new processes; we have created a GlyEco University to aggregate our chemistry and technology advancements; and we have begun working with our customers, large and small, on their own quality control and assurance programs.

Strategic Objective #2: GlyEco will focus on maximizing the profitable businesses we own, leverage the expertise of our entrepreneurial managing partners, and work with our national customers to increase same-store revenues. We will also focus on satellite locations where we will expand our sales and delivery routes in areas we believe positively impact our topline revenue and bottom line profitability.

Update: As a result of focus and reduced distractions, our team had the opportunity to create a strong revenue quarter for GlyEco. We believe our revenues will exceed all quarterly records with South Carolina, Florida, and New Jersey reaching historical highs. In June, we presented an outline to our national partners of our expansion strategy and will continue to push forward to develop opportunities. We closed our second national account on June 15th and have begun servicing the new client’s 65 facility maintenance centers. We believe additional opportunities with a broad impact on our facilities will occur by year-end and we are eager to meet the quality and service needs of these new national customers. Our third quarter expansion plans, via satellite sales and delivery, will expand our reach into new states and territories. These are areas where our current customers have needs. In May, we upgraded one of our processing facilities to exceed 300% production capacity over 2014 in order to support our satellite distribution facility, what we refer to as hub-and-spoke model, to meet customer demands and support our territorial growth plans. Same-store sales are increasing and will continue as we focus on execution of our brand initiatives, deliver exceptional quality and service to existing customers, and leverage our QC&A Program and Field Operations Program to expand the footprint. July, August, and September are traditionally slower months in the glycol industry; however, we intend to push our opportunities forward, secure new national business, and prepare for what we expect to be a strong October, November, and December quarter.

Strategic Objective #3: GlyEco will deploy field technology to support the automation and logistical requirements for growth. We will deploy smart routing, inventory and quality control, CRM for sales, billing, and payments, which we believe delivers greater control to our managing partners in the field and their teams to increase client acquisition and retention.

Update: On June 1st, we deployed our field automation technology to our South Carolina processing facility, and we plan to deploy to the remainder of our footprint by August 15th. As we drive our business initiatives, our field technology will support additional partner opportunities with national initiatives as well as allow us to service with greater efficiency in payments, deliveries, and routing measures, which we believe will lower our cost of goods and operating expenses. By August 15th, we plan to be able to manage more, service more, and deposit faster throughout our footprint. This is important for our cash flows and critical efficiencies as well as to allow us to service and sell to our customers. Since March 1st, we have added over 750 customers, and as we look to the third and fourth quarter business development, our field technologies will allow us to continue these advancements without incremental expenses.

Strategic Objective #4: GlyEco will continue to deploy its technology throughout our footprint. We have created processes which work and at scale. We will take what we have learned and employ this across our company and search for like-minded companies who wish to partner, license, or become part of the GlyEco family. GlyEco is about its technology and in 2015 we will continue our leadership position in the space. We will establish GlyEco University as the first step to create awareness of the glycol industry, why it is important to recycle this waste stream, and the value it returns our customers and our communities. We will advance GlyEco University to our national partners, train them and help them establish standards for quality and processes to insure consistency for their customers.

Update: Quality Glycol is our DNA – our “why.” GlyEco is a recycler of waste glycol streams within the domestic United States. Our seven processing centers deliver superior quality glycol products using our innovative chemistry we call “The Platform” which encompasses our GlyEco University, QC&A Program, automated field operations, and proprietary glycol science. Our company delivers a fully integrated solution to the glycol, blend and antifreeze industries. Our industry leading Quality Assurance & Control Committee is led by our facility managing partners, and we have accepted our first national partner into our GlyEco University, which will launch on July 17th with ten or more sales, marketing, and engineering students. Our QC&A Program encompasses twenty-four (24) control modules from feedstock arrival through pre-treatment, primary treatment, post treatment, and final product testing and analysis including three tiers of review by internal and external third part testing and analysis. We will continue developing GlyEco University as our repository for our intellectual property gains and product training for our national partners, along with our internal QC&A Program to insure our products exceed the industry. Our customers expect nothing less and we will continue to deliver nothing less. As our product line continues to evolve to meet the needs of our customers, we will utilize the GlyEco University as our repository for our science and engage with partners in the art.

GlyEco will continue to improve its flexibility during 2015.

Flexibility is one of our cultural characteristics and key-differentiating competency. Our operational flexibility enables us to efficiently redeploy certain manufacturing assets when demand shifts between product types, an advantage in today’s fast-changing business environment. We deliver blended finished products to the specifications our customers demand as well as deliver clear recycled products in bulk delivery for our clients to finish as needed for their customers. GlyEco is a technology company first and foremost, which allows our chemistry and intellectual property to travel to meet the needs of our customers. Our technology provides the flexibility to support our future growth as we expand further our sales and delivery footprint. Where we have delivery routes via truck reach, as outlined above, we will continue to advance outwards. However, where our delivery reach is not cost effective, we will continue to leverage our technology to ship in bulk to partners as a white label product.

To partner or to start a project with us please visit: Start a Project with GlyEco! With our technology, our long-term goal is to deliver a single platform for glycol sustainability and consolidation to ensure predictable and dependable quality and service throughout the industry. We believe our industry leadership will allow us over time to be the single point for predictable and dependable recycled glycol. Again, this is our passion. It is our DNA.

Our Team

Companies that grow and thrive over the long term usually do so because of a number of factors, including a clear sense of direction, market leadership, quality products, and effective business models supported by vibrant cultures, solid business approaches, and talented employees with the ability to execute. The flexibility to adapt to changing business conditions is also important. We strive to have all these attributes contribute to our success. Our greatest resource continues to be found within our team. We are fortunate to have a very capable, highly skilled group of people within our organization, and we will continue to recruit and advance our human resources. During the second quarter, we developed committees to support our strategies. Two of these committees, the Field Technology Committee and Quality Control and Assurance Committee are led by our facility managers and volunteers to advance our initiatives throughout our footprint. GlyEco University institutionalizes our passions to deliver superior products and services to our customers. It enhances our differentiation and has been instrumental in helping us achieve new levels of performance. It is critical to our success. I continue to be impressed by the success stories generated by the leaders who work within our processing facilities. We initiated change in our Company’s culture, and we will continue to refine and develop our team into the future.

All our stakeholder relationships are very important to us and our success. We have worked diligently in 2015 to advance the organization while institutionalizing our technology processes both chemistry and operations. We have not, however, communicated much to the market our activities, as we believe the next few quarters are about execution and working through our growing pains. The technology works, and our rising customer counts are a result of our recent focus and delivery. We will work harder in the future to communicate our successes, as they relate to our four strategic objectives above, as we achieve them and not before they become attributable to driving shareholder value.

We continue to work with our New Jersey landlord to resolve our outstanding dispute. However, it should be noted that our team achieved record volumes shipped and revenues generated during the second quarter while ongoing negotiations continued. Our intent is to mitigate distractions for our New Jersey team, however, as we discussed in our last shareholder call, our Company has and continues to work within our contractual obligations. We will continue to invest in our facilities, including New Jersey, to the extent we achieve a compelling return on those investments and to the extent the distractions do not interfere with our growing and profitable footprint. In addition, we will continue to initiate change within our organization, as needed, to sustain our growing business and to establish an accountable and entrepreneurial culture.

Closing Remarks

In closing, our team is focused on driving business growth and profitability through consolidating the industry, deploying our proven technology and chemistry, and creating a predictable and dependable partner for our regional and national opportunities. We have succeeded in partnering with and servicing multiple national customers during the first half of 2015, brands you know and trust, and we will continue to attract large national customers as we relentlessly strive for greater share of this fragmented industry. We believe our quality, service, technology experience, and exceptional human resources will advance GlyEco into higher-priced and less competitive markets, as we lift the industry for sustained glycol products.

Thank you for your investment in GlyEco, Inc., and thank you for your continued support.

Sincerely,

David Ide
Interim Chief Executive Officer and President

About GlyEco, Inc.

GlyEco is a green chemistry company with a patent-pending technology for transforming a hazardous waste into green products. GlyEco Technology(TM) has the unique ability to clean the polluted glycols from all five waste-producing industries: HVAC, Textiles, Automotive, Airline and Medical. This technology recycles waste glycol to meet ASTM Type 1 specifications – the same level of purity expected of refinery-grade glycols.

Safe Harbor Statement

This news release contains forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are often identified by the words “believe,” “anticipate,” “expect,” “intend,” “estimate,” and similar expressions. All statements in this document regarding the future outlook related to GlyEco, Inc. are forward-looking statements. Such statements are based on the current expectations, beliefs, estimates and projections of management and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements including the risk that the future data will not be as favorable as the initial results. Additional uncertainties and risks are described in our most recent Annual Report on Form 10-K. For a more detailed discussion of factors that affect GlyEco’s operations, please refer our filings with the Securities and Exchange Commission (“SEC”). Copies of these filings are available through the SEC website at http://www.sec.gov. All forward-looking statements are based upon information available to us on the date hereof, and GlyEco undertakes no obligation to update this forward-looking information.

CONTACT:


GlyEco, Inc.

Telephone: 1-866-960-1539

Email: ir@glyeco.com

SOURCE: GlyEco, Inc.

ReleaseID: 430605

MARINA DEL REY,CA / ACCESSWIRE / July 16, 2015 / Discovery Minerals Ltd. (PINKSHEETS: DSCR) (Discovery)
Discovery Minerals Ltd., and AB AGRO Technologies Inc. (AB AGRO) are excited to
announce that they have signed an agreement to distribute an innovative new hemp-based
pet care product.

This exciting new product will be an affordable, environmentally friendly, naturally superior product, entering into a market with currently over 2 billion dollars a year in sales in North America. AB AGRO intends to leverage the existing distribution channel formed though the IB-8 joint venture. Utilizing the distribution partner within South Florida will afford a low-cost entry into this pet care market.

As was indicated in our last release on hemp and sunflower seeds, it is estimated that 180,000 bottles of hemp and sunflower seed snacks can potentially be retailed over the next six months through the same distribution channel. These estimates show the exciting potential gross revenues to be in excess of $600,000. Additionally, the increased number of sales is anticipated to reduce IB-8’s cost of goods by a factor of 10% over the next six months.

About Discovery Minerals LTD.:

Discovery Minerals Ltd., (PINKSHEETS: DSCR) is an acquisition and development company that targets natural resource properties through its subsidiaries. These properties fall within two primary channels, precious metals/mining and industrial hemp. Discovery subsidiaries engage in activities that include the cultivation, product development, and distribution of industrial hemp; Gold, silver and precious metals. In addition, the Company is pursuing clean tech and alternative energy investments to be integrated into these business channels.

About I-B8

I-B8 is an established boutique sunflower seed snack company known for their seed quality, craftsmanship and unique flavors.

Customers who join the I-B8 Seed Club are able to recycle I-B8 packaging in exchange for discounts and free samples of new products at www.i-b8.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and
results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Contact Person:

Russell Smith
At: info@discoveryholdingscorp.com
1-310-961-4654

SOURCE: Discovery Minerals Ltd.

ReleaseID: 430629